ANNA TAYLOR: Open Payments
NPI 1578899845 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,857 in 69 payments from 10 companies in 2025. Trend: 2023 $2,049 · 2024 $2,296 · 2025 $2,857
Food & beverage: $2,772Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $1,254 |
| Janssen Biotech, Inc. | 7 | $502 |
| Madrigal Pharmaceuticals | 11 | $362 |
| Gilead Sciences, Inc. | 7 | $143 |
| Novo Nordisk Inc | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $120 |
| Ardelyx, Inc. | 1 | $118 |
| Janssen Scientific Affairs, LLC | 1 | $109 |
| EVOKE PHARMA, INC. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 1 | $53 |
Products named: TREMFYA, SKYRIZI, RINVOQ, REZDIFFRA, VOQUEZNA, IBSRELA, Epclusa, MAVYRET.
Industry payments across TX — which companies pay providers there.
